In this study, we primarily quantified lncRNA CASC9 in patients with advanced colon cancer (ACC) and analyzed its prognostic value for such patients, with the goal of providing promising prognostic markers for CC in clinical practice. This evidence concerns the gene CASC9 and adrenal cortex carcinoma.